Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.
S-Nitrosylation of Tissue-Type Plasminogen Activator Confers Vasodilatory and Antiplatelet Properties on the Enzyme
Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.
Fibrinolytic properties of one-chain and 2-chain human extrinsic (tissue-type) plasminogen-activator
Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke: The Standard Treatment with Alteplase to Reverse Stroke...
Endogenous tissue-type plasminogen activator and risk of myocardial infarction.
Patients With the Malignant Profile Within 3 Hours of Symptom Onset Have Very Poor Outcomes After Intravenous Tissue-Type Plasminoge...
Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
Endogenous tissue-type plasminogen activator and myocardial infarction
